**Legal Notice and Disclaimer of Liability NanoLabsMed Corporation, S.A.**
Preliminary Statement on Service Scope.
NanoLabsMed Corporation, S.A. (hereinafter, “the Corporation”) operates solely and exclusively as an independent, third-party analytical laboratory. The services provided are confined to the technical evaluation, characterization, and quantification of compounds, active ingredients, or pharmacological formulations, performed exclusively upon the specific physical samples submitted by the client (hereinafter, “the Samples”), in the precise state and condition in which they were received for analytical processing.
Inherent Limitation of Reported Results.
The data, reports, analytical certificates, and any other outputs derived from laboratory procedures (collectively, “the Results”) possess an intrinsic validity strictly limited to the context of the Samples analyzed under the specific applied methodological conditions. NanoLabsMed Corporation, S.A. does not extend, implicitly or explicitly, the validity of these Results to other manufacturing batches, product units, or the general quality of the commercial product from which the Samples originated. The Corporation disclaims all responsibility for variations attributable to manufacturing processes, stability, storage conditions, or logistical handling over which it exercises no control.
Absence of Value Judgments and Commercial Endorsement.
The issuance of Results by the Corporation shall in no way be construed as a quality certification, an endorsement, a guarantee of efficacy or safety, a usage recommendation, or a promotion or disapproval of the finished product, its manufacturer, or any related commercial entity. The Corporation’s role is strictly limited to reporting objective analytical findings based on the Samples received and it expressly refrains from making any pronouncements regarding the overall suitability, safety, or commercial quality of the sourced product. Any interpretation in this regard falls entirely outside the Corporation’s purview and accepted responsibilities.
Critical Warning on Pharmaceutical Use and Professional Supervision.
The Corporation must underscore in the most emphatic terms that the technical information contained within its Results does not, under any circumstances, constitute medical advice, a diagnosis, or a prescription. The consumption, administration, or use of any pharmaceutical product or active ingredient must be conducted solely under the direct supervision, prescription, and ongoing monitoring of a qualified healthcare professional. This serves as an explicit warning regarding the severe health risks, including the potential for adverse reactions, drug interactions, or other harmful effects, associated with self-medication or any deviation from the directives of a medical professional.
Acceptance and Indemnification Clause.
The submission of Samples for analysis and the subsequent acceptance of the Results constitutes the client’s full and unconditional acceptance of all terms and limitations set forth in this legal notice. The client thereby agrees to indemnify and hold harmless NanoLabsMed Corporation, S.A., its directors, officers, employees, and agents, from any and all claims, liabilities, damages, or losses that may arise from the use, misinterpretation, or application of the Results beyond their strictly defined and intended technical purpose.